The rapid development of the healthcare industry in China has accelerated efforts to communicate between the various factions within the sector. An example earlier this year was a customized training program undertaken by Cornerstone in Taiwan. The client was a large pharma company and the task was to enable scientific exchange between company personnel and […]
Financing healthcare around private insurance has been tried but not been successful. The Chengdu pilot would be the first real mutual insurance in China.
2019 is now really starting in China, with the beginning of the Year of the Pig. Everybody in the China pharma market is focusing on how the new central purchasing pilot will be deployed in the coming months. At first glance it looks familiar, with convergence with known international practices: strengthening of bidding rules, phasing […]